nyse:myov
|
16179516
|
Apr 21st, 2024 12:00AM
|
Myovant Sciences
|
22K
|
192.00
|
Open
|
|
Apr 21st, 2024 04:18AM
|
Apr 21st, 2024 04:18AM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 20th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
192.00
|
Open
|
|
Apr 20th, 2024 03:20AM
|
Apr 20th, 2024 06:39PM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 19th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
191.00
|
Open
|
|
Apr 19th, 2024 05:42AM
|
Apr 19th, 2024 05:42AM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 18th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
191.00
|
Open
|
|
Apr 18th, 2024 04:20AM
|
Apr 18th, 2024 07:59PM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 17th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
194.00
|
Open
|
|
Apr 17th, 2024 05:40AM
|
Apr 17th, 2024 04:27PM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 16th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
194.00
|
Open
|
|
Apr 16th, 2024 02:49AM
|
Apr 16th, 2024 12:43PM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 15th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
195.00
|
Open
|
|
Apr 15th, 2024 06:01AM
|
Apr 15th, 2024 06:24PM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 14th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
196.00
|
Open
|
|
Apr 14th, 2024 01:04AM
|
Apr 14th, 2024 01:04AM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 13th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
197.00
|
Open
|
|
Apr 13th, 2024 12:46AM
|
Apr 13th, 2024 01:08PM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|
nyse:myov
|
16179516
|
Apr 12th, 2024 12:00AM
|
Myovant Sciences
|
22K
|
197.00
|
Open
|
|
Apr 12th, 2024 12:57AM
|
Apr 12th, 2024 10:07AM
|
Myovant Sciences Inc. is now Sumitomo Pharma America (SMPA), while Myovant Sciences GmbH is Sumitomo Pharma Switzerland GmbH (SMPS). We are a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need. See pinned post for our new page and follow us! ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀⠀⠀⠀ ⠀
====
We aspire to be the leading healthcare company focused on redefining care for women’s health and prostate cancer. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer. We strive to improve the lives of millions of people, while building an innovative, dynamic, and collaborative company where employees thrive.
Read our LinkedIn Community Guidelines at http://myovant.com/community-guidelines
|
Open
|
|
Open
|
2000 Sierra Point Parkway
|
Brisbane
|
CA
|
US
|
94005
|
|
Myovant Sciences
|
|
|